| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8475460 | Journal of Molecular and Cellular Cardiology | 2011 | 8 Pages | 
Abstract
												⺠Cardiac hypertrophy is a major risk factor for adverse cardiovascular events and death. ⺠Hypertrophy is physiological as with exercise or pathological as with hypertension. ⺠We discuss recent developments in 3 areas fundamental to pathological cardiac hypertrophy. ⺠Recent studies on TRPC channels, mTOR, and HDAC enzymes provide new clues into cardiac hypertrophy.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cell Biology
												
											Authors
												Mazen Kurdi, George W. Booz, 
											